July 2, 2019
During the third week of May, the ITN gathered in Seattle with members of the NSC, NIAID, and Rho for ITN’s first Network Steering Committee meeting of 2019. We accomplished quite a bit in our short time together.
The recommendations from the NSC to approve moving forward with the anti-CD40L autoimmune and transplant proposals along with the transplant desensitization proposal were all approved for feasibility assessment by the Network Executive Committee.
We have posted the presentations for these studies as well as the presentations for the clinical and mechanistic studies from the ITN portfolio on our document portal.
As you know all of the meeting material is confidential and may not be redistributed.
More Information
